Alzheimer’s Drug Discovery Foundation Funds AgeneBio To Advance Pharmacological Neural Stabilizer Technology
DRUG ADDICTION REHAB Comments OffAlzheimer’s Drug Discovery Foundation Funds AgeneBio To Advance Pharmacological Neural Stabilizer Technology
The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded a grant of 0,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer’s disease and affects more than 3 million aging Americans. Approximately fifteen percent of aMCI patients …
Read more on Medical News Today
Rehab biz calls to Lohan dad
Dina Lohan told Matt Lauer that daughter Lindsay will be moving back to New York after her legal troubles are over. Maybe now we know why she wants to get out of California.
Read more on Detroit Free Press
Servier’s Procoralan Cuts Heart-Failure Death, Hospital Stays, Study Says
Researchers tracked more than 6,500 people with severe heart failure, including those who had a recent hospitalization, poor cardiac pumping power and a heart rate of at least 70 beats per minute at rest.
Read more on Bloomberg
Recent Comments